Implantica AG
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipel… Read more
Market Cap & Net Worth: Implantica AG (IMP-A-SDB)
Implantica AG (ST:IMP-A-SDB) has a market capitalization of $34.27K (Skr384.47K) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #23627 globally and #299 in its home market, demonstrating a -8.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Implantica AG's stock price Skr40.25 by its total outstanding shares 9552 (9.55K).
Implantica AG Market Cap History: 2020 to 2026
Implantica AG's market capitalization history from 2020 to 2026. Data shows change from $118.19K to $34.27K (-14.77% CAGR).
Implantica AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Implantica AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Implantica AG's market cap is 0.02 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $118.19K | $152.00K | -$10.28 Million | 0.78x | N/A |
| 2021 | $55.35K | $387.00K | -$15.36 Million | 0.14x | N/A |
| 2022 | $33.85K | $842.00K | -$20.82 Million | 0.04x | N/A |
| 2023 | $20.35K | $1.41 Million | -$23.74 Million | 0.01x | N/A |
| 2024 | $29.29K | $1.94 Million | -$23.33 Million | 0.02x | N/A |
Competitor Companies of IMP-A-SDB by Market Capitalization
Companies near Implantica AG in the global market cap rankings as of March 19, 2026.
Key companies related to Implantica AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Implantica AG Historical Marketcap From 2020 to 2026
Between 2020 and today, Implantica AG's market cap moved from $118.19K to $ 34.27K, with a yearly change of -14.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr34.27K | -19.66% |
| 2025 | Skr42.66K | +45.64% |
| 2024 | Skr29.29K | +43.93% |
| 2023 | Skr20.35K | -39.87% |
| 2022 | Skr33.85K | -38.85% |
| 2021 | Skr55.35K | -53.17% |
| 2020 | Skr118.19K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Implantica AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.27K USD |
| MoneyControl | $34.27K USD |
| MarketWatch | $34.27K USD |
| marketcap.company | $34.27K USD |
| Reuters | $34.27K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.